Topic

Kenneth Getz is a senior research fellow at the Tufts Center for the Study of Drug Development.

Articles

Comparing late-stage COVID-19 vaccine trials to historical practices.

Investigative Site Placement Practices to Support Operation Warp Speed

Findings from a Tufts study examining the effects of COVID-19 on clinical trials.

COVID-19 and Its Impact on the Future of Clinical Trial Execution

Lessons from six months of conducting clinical trials during the COVID-19 pandemic

Where Do We Go From Here?

Hassan Kadhim, Director, Global Head of Clinical Trial Business Capabilities, Clinical Innovation & Industry Collaborations at Bristol Myers Squibb, discusses his perspectives on how the pandemic has shifted clinical innovation.


COVID Shifts Clinical Innovation in Big Pharma

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success. 

Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 World

Exploring effective strategies for sponsors and CROs to ensure both their CRAs and sites are supported for high levels of site acceptance and streamlined remote monitoring.

4 Tactics to Encourage Your CRAs and Sites to Adopt Remote Site Monitoring

The pandemic has thus far disproportionally impacted minority populations, and our ongoing failure to adequately represent all patients regardless of demographic background has never been more important to remedy than it is today, writes ACRP Workforce Innovation Officer Beth Harper. 

The Time is Now to Promote Clinical Trial Workforce Diversity

Creative approaches are needed to address the clinical research workforce “talent wars”

A Competency-Based Approach to Combating the Talent Wars in BioPharma

Exploring how clinical research sites are redefining their business models to be more flexible, collaborative, and customized.   

The Changing Landscape for Clinical Trial Sites

A case study of the Parkinson’s Progression Markers Initiative.

Investigative Sites